Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
The current price of 1HOLX.MI is €63.5 EUR — it has decreased by -1.55% in the past 24 hours. Watch Hologic stock price performance more closely on the chart.
What is Hologic stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Hologic stocks are traded under the ticker 1HOLX.MI.
What is Hologic market cap?▼
Today Hologic has the market capitalization of 14.15B
When is the next Hologic earnings date?▼
Hologic is going to release the next earnings report on April 30, 2026.
What were Hologic earnings last quarter?▼
1HOLX.MI earnings for the last quarter are 0.87 EUR per share, whereas the estimation was 0.92 EUR resulting in a -5.08% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Hologic revenue for the last year?▼
Hologic revenue for the last year amounts to 7.18B EUR.
What is Hologic net income for the last year?▼
1HOLX.MI net income for the last year is 985.93M EUR.
How many employees does Hologic have?▼
As of February 02, 2026, the company has 6,944 employees.
In which sector is Hologic located?▼
Hologic operates in the Healthcare sector.
When did Hologic complete a stock split?▼
Hologic has not had any recent stock splits.
Where is Hologic headquartered?▼
Hologic is headquartered in Marlborough, United States.